Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2026	Feb. 01, 2025	Feb. 03, 2024
Operating Activities:
Net Income	$ 189	$ 169	$ 116
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization	238	258	284
Adore Me Long-Lived Assets Impairment Charges	120	0	0
Share-based Compensation Expense	55	60	56
Deferred Income Taxes	(49)	(29)	(16)
Payments for Contingent Compensation related to Adore Me Acquisition	1	39	0
Equity Method Investment Impairment Charges	0	19	0
Gain on Sale of Assets	0	(7)	0
Amortization of Fair Value Adjustment to Acquired Inventories	0	0	29
Changes in Assets and Liabilities:
Accounts Receivable	(24)	(8)	(13)
Inventories	(112)	29	36
Accounts Payable, Accrued Expenses and Other	114	(78)	(11)
Income Taxes	15	14	(26)
Other Assets and Liabilities	(46)	37	(66)
Net Cash Provided by Operating Activities	499	425	389
Investing Activities:
Capital Expenditures	(187)	(178)	(256)
Proceeds from Sale of Assets	0	25	0
Acquisition, Net of Cash Acquired	0	0	1
Other Investing Activities	3	0	1
Net Cash Used for Investing Activities	(184)	(153)	(254)
Financing Activities:
Repayments of Borrowings from Asset-based Revolving Credit Facility	(545)	(605)	(615)
Borrowings from Asset-based Revolving Credit Facility	545	460	465
Tax Payments related to Share-based Awards	(15)	(10)	(12)
Payments for Contingent and Deferred Consideration related to Adore Me Acquisition	(4)	(161)	0
Proceeds from Stock Option Exercises	4	5	3
Payments of Long-term Debt	(4)	(4)	(4)
Repurchases of Common Stock	0	0	(125)
Other Financing Activities	(5)	0	(3)
Net Cash Used for Financing Activities	(24)	(315)	(291)
Effects of Exchange Rate Changes on Cash and Cash Equivalents	0	0	(1)
Net Increase (Decrease) in Cash and Cash Equivalents	291	(43)	(157)
Cash and Cash Equivalents, Beginning of Period	227	270	427
Cash and Cash Equivalents, End of Period	$ 518	$ 227	$ 270